In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Retatrutide, Retatrutide vs. Tirzepatide, Retatrutide vs. Semaglutide, Retatrutide vs. Cagrilintide CagriSema vs Tirzepatide: Weight Loss Results in REDEFINE 4 Trial Paramesh Shamanna posted on the topic LinkedIn MAA Semaglutide and Cagrilintide vs Tirzepatide.docx For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram